임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

23건 표시

1상모집 중· Sanfilippo Syndrome Type A
Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
리드: GC녹십자
상세 →NCT06567769
1상상태 미확인· Healthy Volunteers
A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed Conditions
리드: GC녹십자
상세 →NCT05729386
1상상태 미확인· Healthy Volunteers
A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fasting Conditions
리드: GC녹십자
상세 →NCT05703984
1상모집 중단 (진행 중)· Mucopolysaccharidosis II
A Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ
리드: GC녹십자
상세 →NCT05422482
1상완료· Hemophilia
A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia Patient
리드: GC녹십자
상세 →NCT05493631
1상완료· Hemophilia
A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients
리드: GC녹십자
상세 →NCT03855696
1상완료· Herpes Zoster
Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects
협력: GC녹십자
상세 →NCT03820414
1상상태 미확인· Tuberculosis
Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults
리드: GC녹십자
상세 →NCT03363178
1상완료· Influenza, Human
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults
리드: GC녹십자
상세 →NCT03357263
1상완료· Chronic Hepatitis B
A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients
리드: GC녹십자
상세 →NCT02569372
1상완료· Varicella (Chicken Pox)
Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults
리드: GC녹십자
상세 →NCT02367638
1상상태 미확인· Neoplasm Metastasis
Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer
리드: GC녹십자
상세 →NCT02352571
1상완료· Healthy Volunteers
A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers
리드: GC녹십자
상세 →NCT01954238
1상완료· Fabry Disease
Evaluate the Safety and Exploratory Efficacy of GC1119
리드: GC녹십자
상세 →NCT01653444
1상완료· Hepatitis B
Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection
리드: GC녹십자
상세 →NCT01606163
1상완료· Healthy Male
A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers
리드: GC녹십자
상세 →NCT01651234
1상완료· Healthy Volunteer
To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin
리드: GC녹십자
상세 →NCT01363934
1상조기 종료· Solid Tumors
Safety Study of MG1102 in Patients With Solid Tumors
리드: GC녹십자
상세 →NCT01809912
1상완료· Malignant Lymphomas
Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor
협력: GC녹십자
상세 →NCT01212341
1상완료· Breast Cancer
Safety Study of MGAH22 in HER2-positive Carcinomas
협력: GC녹십자
상세 →NCT01148849
1상완료· Anthrax
Efficacy and Safety of Anthrax Vaccine, GC1109
협력: GC녹십자
상세 →NCT01867957
1상완료· Healthy
Pharmacokinetics and Pharmacodynamics of a Novel Pegylated Recombinant Human Granulocyte-Colony Stimulating Factor
협력: GC녹십자
상세 →NCT00969826
1상완료· Neoplasms, Liver
A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma
협력: GC녹십자
상세 →NCT00629759

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.